SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000912282-08-001571
Filing Date
2008-10-30
Accepted
2008-10-30 14:56:42
Documents
2
Period of Report
2008-10-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 oncogenex8k_102808.htm 8-K 16494
2 THIRD AMENDED AND RESTATED BYLAWS ex3_4.htm EX-3.4 84288
  Complete submission text file 0000912282-08-001571.txt   102433
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
ONCOGENEX PHARMACEUTICALS, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 081150747
SIC: 2835 In Vitro & In Vivo Diagnostic Substances